Form 4: Koru Medical Systems Director John Fletcher Reports Acquisition of Shares
SEC Form 4 Filing
John Fletcher, a director at Koru Medical Systems, reported acquiring 5,905 shares of common stock at $3.81 per share on January 3, 2025.
Summary
- On January 3, 2025, John Fletcher, a director and Chairman of the Board at Koru Medical Systems, acquired 5,905 shares of common stock.
- The shares were purchased at a price of $3.81 per share.
- Following the transaction, Fletcher's total beneficial ownership in Koru Medical Systems is 196,756 shares.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. A director purchasing shares can be seen as a vote of confidence, but it's a relatively small transaction.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 01/03/2025 | Date of transaction: John Fletcher acquired 5,905 shares of Koru Medical Systems common stock. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.